Llwytho...
Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma
BACKGROUND: Despite the recent improvements in multimodal therapies for oesophageal squamous cell carcinoma (ESCC), the prognosis remains poor. The identification of suitable biomarkers for predicting the prognosis and chemo-sensitivity is required to develop targeted treatments and improve treatmen...
Wedi'i Gadw mewn:
Cyhoeddwyd yn: | Br J Cancer |
---|---|
Prif Awduron: | , , , , , , , , , , , , , , , , , , , , |
Fformat: | Artigo |
Iaith: | Inglês |
Cyhoeddwyd: |
Nature Publishing Group
2016
|
Pynciau: | |
Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4931380/ https://ncbi.nlm.nih.gov/pubmed/27310703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.183 |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|